Publish in this journal
Journal Information
Vol. 40. Issue 2.
Pages 90-95 (March 2016)
Vol. 40. Issue 2.
Pages 90-95 (March 2016)
DOI: 10.1016/j.medine.2016.02.001
Full text access
Accessibility to health care of diabetic patients with acute coronary syndrome ST-segment elevation
Accesibilidad al sistema sanitario de los pacientes diabéticos con síndrome coronario agudo con elevación del segmento ST
A. Baeza-Romána,
Corresponding author

Corresponding author.
, E. de Miguel-Balsaa, J. Latour-Péreza, V. Díaz de Antoñana-Saezb, J. Arguedas-Cerverac, E. Mira-Sánchezd, C.J. Fernández-Gonzáleze, M. Rico-Salaf, M. Lafuente-Mateog, ARIAM-SEMICYUC Group
a Unidad de Cuidados Intensivos, Hospital General Universitario de Elche, Elche, Spain
b Unidad de Cuidados Intensivos, Complejo Hospital San Pedro, Logroño, Spain
c Unidad de Cuidados Intensivos, Hospital General de Castelló, Castellón, Spain
d Unidad de Cuidados Intensivos, Hospital General Universitario Reina Sofía, Murcia, Spain
e Unidad de Cuidados Intensivos, Complejo hospitalario Arquitecto Marcide–Prof. Novoa Santos, Ferrol, Spain
f Unidad de Cuidados Intensivos, Hospital Arnau de Vilanova, Valencia, Spain
g Unidad de Cuidados Intensivos, Hospital Nuestra Señora de Gracia, Zaragoza, Spain
Article information
Full Text
Download PDF
Figures (1)
Tables (3)
Table 1. Baseline characteristics and evolution. Patients with ACSSTE (n=4817).
Table 2. Times related to patient-attributable delay and health care system-attributable delay (expressed in minutes, with median and interquartile range).
Table 3. Binary logistic regression model.
Show moreShow less

To measure accessibility to health care among diabetic patients and analyze whether differences in delay explain differences in hospital mortality.


A retrospective cohort study was conducted in diabetic patients with acute coronary syndrome with ST-segment elevation included in the ARIAM-SEMICYUC registry (2010–2013). Crude and adjusted analyses were performed using unconditional logistic regression.


A total of 4817 patients were analyzed, of whom 1070 (22.2%) were diabetics.

No differences were found in access to health care between diabetic and non-diabetic patients. Diabetic patients presented with longer patient delay (90min vs. 75min; p=.004) and prehospital delay (150min vs. 130min; p=.002). Once the health system was contacted, diabetic patients had a lower reperfusion rate (50% vs. 57.7%; p<.001), but no longer delay in treatment was observed compared with the non-diabetic individuals. Diabetic patients have greater in-hospital mortality (12.5 vs. 6%; p<.001), though neither patient delay nor prehospital delay was identified as independent predictors of in-hospital mortality.


Diabetic patients had a longer delay in access to health care, though such delay was not independently related to increased mortality.

Diabetes mellitus
Acute coronary syndrome with ST-segment elevation
Health care

El objetivo de este estudio es medir la accesibilidad al sistema sanitario de los pacientes diabéticos y analizar si las posibles diferencias en la accesibilidad explican la mayor mortalidad conocida en aquellos.


Estudio de cohortes retrospectivo, realizado en pacientes diabéticos con síndrome coronario agudo con elevación del segmento ST incluidos en los años 2010 al 2013 del registro ARIAM-SEMICYUC. Se realiza análisis crudo y ajustado mediante regresión logística no condicional.


Se han analizado 4817 pacientes, de los cuales 1070 (22,2%) son diabéticos. Los pacientes diabéticos contactan con el sistema sanitario de la misma forma que los pacientes no diabéticos aunque con mayor retraso (retraso atribuible al paciente 90min vs. 75min con p=0,004 y retraso prehospitalario 150min vs. 130min con p=0,002). Una vez dentro del sistema sanitario, estos pacientes tienen menor tasa de reperfusión (50 vs. 57,7%; p<0,001) pero sin objetivar mayor retraso en el tratamiento. Como ya es conocido, los pacientes diabéticos presentan una mayor mortalidad hospitalaria (12,5 vs. 6%; p<0,001); sin embargo, no se identifican como variables predictoras independientes de la mortalidad ni el retraso atribuible al paciente ni el retraso prehospitalario.


Los pacientes diabéticos tienen una mayor demora en el acceso al sistema sanitario, sin embargo no hemos podido objetivar que esta demora se relacione de forma independiente con la mayor mortalidad.

Palabras clave:
Diabetes mellitus
Síndrome coronario agudo con elevación de ST
Sistema sanitario
Full Text

In patients presenting acute coronary syndrome (ACS) with ST-segment elevation (ACSSTE), reperfusion treatment should be provided as soon as possible, and always within the first 12h after symptoms onset.1,2 The total reperfusion time basically comprises two phases: the time taken by the patient to contact the health care system after symptoms onset (patient-attributable delay) and the time from patient contact to the start of reperfusion treatment (health care system-attributable delay).

A number of studies have shown that diabetic patients with ACSSTE take longer in contacting the health care system after symptoms onset,3–7 and this delay has a number of consequences. On one hand it directly influences the decision to perform reperfusion and the choice of treatment provided (fibrinolysis versus percutaneous coronary intervention [PCI]), while on the other hand a longer initial delay contributes to longer total reperfusion times and therefore to more prolonged myocardial ischemia. Of the different factors that may explain this greater delay among diabetic patients, the atypical nature of their symptoms play a particularly important role.3,5,8

The present study aims to determine whether there are differences in accessibility to the health care system (access and reperfusion times) between diabetic patients and no-diabetic individuals. An evaluation is made of the different factors that might influence such differences, and finally an analysis is performed to determine whether differences in delay are able to account for the greater mortality observed among diabetic patients.


A retrospective cohort study was carried out, based on the data of the ARIAM-SEMICYUC registry, which includes the participation of different Spanish hospitals.9 This registry complies with Spanish legislation on observational post-authorization studies with drugs destined for human use (Order SAS/3470/2009, of 16 December). In addition, recognition as a registry of interest for the national health system was received in May 2012.

Data were collected on those consecutive patients admitted to the Intensive Care Unit (ICU)/Coronary Unit diagnosed upon admission with ACSSTE in the period 2010–2013.

The study variables comprised sociodemographic data (age, gender) and information referred to access to the health care system (place of first contact, form of transfer to hospital), the clinical presentation of ACS (electrocardiogram, first symptom), clinical characteristics upon admission (Killip–Kimball classification, TIMI, GRACE, CRUSADE),10–12 and the reperfusion method used.

Regarding the treatment delays, we analyzed the times attributable to the patient and to the health care system: (a) patient-attributable time (from symptoms onset to first medical contact [FMC]); (b) pre-hospital time (from symptoms onset to arrival in hospital, which coincides with the patient-attributable time in those cases where FMC takes place in hospital); (c) transfer time (in those patients in which FMC does not take place in hospital, this is the time from FMC to arrival in hospital); (d) time from arrival in hospital to administration of fibrinolysis; (e) time from arrival in hospital to PCI; and (f) total reperfusion time censored to 12h (from symptoms onset to reperfusion). We moreover examined mortality in the ICU, in hospital, and after 30 days.

The data were analyzed using the SPSS version 22 statistical package for Mac. In the descriptive statistical analysis, the continuous quantitative variables were expressed as the median and percentiles 25 and 75, while the categorical variables were reported as proportions. Categorical variables were compared using the chi-squared test, while quantitative variables were compared using the Mann–Whitney U-test after confirming non-normal data distribution with the Shapiro–Wilks test. The time variables were analyzed based on Kaplan–Meier survival curves with application of the Breslow test. Two-tailed contrasting of hypotheses was performed, with an alpha level of significance of 5%.

The analysis of mortality was based on the variable hospital mortality, since mortality after 30 days was a non-obligate variable with many data collection losses.

Lastly, binary logistic regression analysis was performed to identify independent predictors of hospital mortality. Different variables yielding a level of significance of <0.1 in the univariate analysis were entered in the regression model. The association between the predictor variables and mortality was assessed by calculating the adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95%CI).


The study included 4685 patients with ACSSTE, of which 22.85% (1070 subjects) suffered diabetes mellitus.

Table 1 presents the findings of the univariate analysis of the main variables. The diabetic patients were older than the non-diabetic individuals, and females predominated. Acute coronary syndrome manifested differently among the diabetic patients, with more frequent atypical pain or no pain. However, the form of access to the health care system was similar in both groups. In this regard, hospital emergency care was the most common FMC. Likewise, no statistically significant differences were observed in the form of transfer to hospital, though diabetic patients tended to be taken to hospital more often by non-medicalized health care transport means and less often by themselves or by a relative.

Table 1.

Baseline characteristics and evolution. Patients with ACSSTE (n=4817).

Baseline characteristics  Patients with ACSSTE (n=4817)p-value 
  DM 22.8% (n=1070/4685)  No DM 77.2% (n=3615/4685)   
Age  68.5 (60–77)  62 (52–74)  <0.001 
Gender (males) (n=4684)  795 (74.3%)  2861 (79.2%)  0.001 
Clinical presentation
First symptom (n=3575)0.003 
No pain  42 (5.3%)  90 (3.2%)   
Typical pain  674 (84.6%)  2464 (88.7%)   
Atypical pain  81 (10.2%)  224 (8.1%)   
Cardiorespiratory arrest (n=3640)  37 (4.6%)  143 (5%)  0.624 
Form of first medical contact (n=4659)0.237 
061-112  208 (19%)  693 (19.3%)   
Physician  44 (4.1%)  162 (4.5%)   
Primary care center  317 (29.9%)  1105 (30.7%)   
Hospital emergency care  396 (37.3%)  1359 (37.8%)   
Hospitalized patients  33 (3.1%)  66 (1.8%)   
Others  63 (5.9%)  213 (5.9%)   
Transfer (n=4560)0.055 
Patient-relative  469 (45.6%)  1693 (47.9%)   
Non-medicalized health care transport  80 (7.8%)  196 (5.5)   
061-112  394 (38.3%)  1363 (38.6%)   
Others  85 (8.3%)  280 (7.9%)   
ECG upon admission (n=4589)<0.001 
ST elevation >2mm on >2 leads  787 (75%)  2787 (78.7%)   
ST elevation <2mm or on <2 leads  230 (21.9%)  709 (20%)   
New CLBB  32 (3.1%)  44 (1.2%)   
Severity upon admission
Initial KK (n=4634)<0.001 
1–2  923 (87.1%)  3333 (93.3%)   
3–4  137 (12.9%)  241 (6.7%)   
TIMI (n=3466)<0.001 
<4  266 (34.5%)  1292 (48%)   
≥4  506 (65%)  1402 (52%)   
GRACE (n=4635)  160 (139–185)  146 (125–172)  <0.001 
CRUSADE (n=4645)  47 (29–57)  37 (20–49)  <0.001 
Reperfusion rate (n=4666)  534 (50%)  3599 (57.7%)  <0.001 
Reperfusion method (n=4666)<0.001 
None  194 (18.2%)  525 (14.6%)   
Thrombolysis  271 (25.4%)  1067 (29.6%)   
Primary PCI  463 (43.4%)  1635 (45.4%)   
Delayed PCI  139 (13%)  372 (10.3%)   
In ICU (n=4515)  82 (8%)  121 (3.5%)  <0.001 
In hospital (n=3746)  109 (12.5%)  175 (6%)  <0.001 
After 30 days (n=2634)  116 (19.2%)  201(9.9%)  <0.001 

CLBB: complete left bundle block; DM: diabetes mellitus; ECG: electrocardiogram; PCI: percutaneous coronary intervention; KK: Killip–Kimball; ACSSTE: acute coronary syndrome with ST-segment elevation; ICU: Intensive Care Unit.

Upon arrival in emergency care, the diabetic patients showed a greater presence of complete left bundle block on the ECG tracing, greater heart failure as assessed by the Killip–Kimball score, and increased severity as determined from TIMI, GRACE and CRUSADE. Furthermore, they presented lower reperfusion rates, with less thrombolysis and PCI and a higher late PCI rate. Mortality in the ICU, in hospital and after 30 days was also higher among the diabetic subjects.

Table 2 shows the analysis of the times attributable to the patient and to the health care system. Diabetic patients were seen to take longer in establishing FMC. This was attributable to a longer pre-hospital delay–the time of transfer to hospital being similar in both patient groups. Once the patient had established contact with the health care system, no differences were observed in the treatment times (emergencies-needle time, emergencies-balloon time, FMC-needle time, FMC-balloon time). All times calculated from symptoms onset were longer among the diabetic patients, since they were influenced by patient-attributable delay (symptoms-needle time, symptoms-balloon time, total reperfusion time).

Table 2.

Times related to patient-attributable delay and health care system-attributable delay (expressed in minutes, with median and interquartile range).

Times  Patients with ACSSTE (n=4817)p-value 
  DM 22.85% (n=1070/4685)  No DM 77.17% (n=3615/4685)   
Patient delay (n=3382)  90 (40–210)  75 (31–183)  0.004 
Pre-hospital delay (n=3709)  150 (82–284)  130 (72–267)  0.002 
Transfer delay (n=1879)  57 (30–90)  53 (26–86)  0.18 
Symptoms-needle time (n=1297)  180 (120–270)  150 (100–250)  0.005 
FMC-needle time (n=934)  80 (50–128)  70 (40–115)  0.115 
Emergencies-needle time (n=1003)  49 (30–84)  42 (28–75)  0.126 
Symptoms-balloon time (n=2554)  450 (210–1956)  375 (190–1560)  0.012 
FMC-balloon time (n=1413)  134 (95–225)  125 (90–196)  0.079 
Emergencies-balloon time (n=1227)  113 (70–192)  105 (62–169)  0.065 
Total reperfusion time (n=2608)  195 (135–285)  175 (120–270)  0.002 

DM: diabetes mellitus; FMC: first medical contact; ACSSTE: acute coronary syndrome with ST-segment elevation.

The analysis of the relationship between total reperfusion time and the reperfusion event showed the diabetic patients to be less likely to be reperfused versus the non-diabetic patients (Fig. 1).

Figure 1.

Relationship between time (min) and reperfusion in diabetic and non-diabetic patients.


The following variables were entered in the regression model: diabetes mellitus, age, patient-attributable delay, reperfusion event, Killip–Kimball score, TIMI, GRACE, CRUSADE, and total reperfusion time. Diabetes and patient severity (TIMI, GRACE and CRUSADE) were identified as independent mortality predictors, though not so patient-attributable delay (Table 3). Furthermore, application of the equation obtained with the model and calculation of the area under the receiver operating characteristic (ROC) curve (=0.9) indicated a very good predictive capacity of the regression model.

Table 3.

Binary logistic regression model.

Predictor variables  OR (95%CI)  p-value 
Patient-attributable delay (h)  1.017 (0.995–1.041)  0.129 
DM  1.51 (1.046–2.181)  0.028 
TIMI  2.314 (1.106–4.841)  0.026 
GRACE  1.031 (1.025–1.036)  <0.001 
CRUSADE  1.031 (1.017–1.045)  <0.001 

DM: diabetes mellitus; CI: confidence interval; OR: odds ratio.


In the present study diabetic patients were seen to present greater patient-attributable delay; as a result, all the times that included this parameter were prolonged in comparison with the non-diabetic individuals. Other authors have published similar findings. The studies of Hasin et al., Woodfield et al. and Goldberg et al. have described longer intervals between symptoms onset and treatment among diabetics compared with non-diabetic individuals.3–5 Ribeiro et al. analyzed patients with ACSSTE according to pre-hospital delay, and found that the group with the longest delays included a larger proportion of diabetic individuals. Furthermore, they identified diabetes as an independent predictor of pre-hospital delays of over 3h.6 Goldberg et al., in a study published after that mentioned above, analyzed data from 14 countries, including Spain (North and South America, Europe, Australia and New Zealand), and found diabetic patients in all these geographical settings to have greater pre-hospital delays.7 However, none of above publications analyzed the possible relationship between this greater pre-hospital delay in diabetics and their increased mortality. In our series, accessibility to the health care system was seen to be similar in diabetic and non-diabetic patients, and once the patients came into contact with the system, the calculated times were similar in both groups. In the year 2002, Colmenero-Ruiz et al. analyzed the differences in the management of patients with ACS among the different Spanish Autonomous Communities, based on the ARIAM registry. They found differences in the form of access to the health care system in the different Communities analyzed, though this was not associated to differences in mortality. There was also important variability in the percentage of diabetic patients from one community to another. However, the possible association between diabetes and the form of access has not been investigated.13 Another finding in our study is the fact that diabetic patients more often experienced atypical symptoms or no pain, which can explain the longer times taken in seeking help. This is consistent with the findings of other authors.5 Leslie et al. analyzed the different causes of pre-hospital delay in patients with ACS–the most frequent reason being problems in correctly interpreting the symptoms and a lack of awareness of the seriousness of the condition.8 In our study we moreover found diabetic patients to have a lesser reperfusion rate and higher mortality–in coincidence with the data reported in the literature.14

Our study was unable to establish an independent association between patient-attributable delay and mortality. The results obtained indicate that the variables independently associated to mortality in patients with ACSSTE are increased initial severity as determined from the TIMI, GRACE and CRUSADE scores, and the existence of diabetes mellitus.

The main limitation of our study is referred to patient follow-up from hospital discharge. For the mortality analysis we decided to use the variable hospital mortality, due to the large data losses associated to the variable mortality after 30 days–though we also consider such losses to be random, and therefore feel that they do not bias our results.

On the other hand, this is a multicenter study involving centers from all over Spain–a fact that ensures a study sample clearly representative of the Spanish population.


Diabetic patients take longer in contacting the health care system, though what appears to condition the increased mortality observed in these patient is not the delay in FMC but the fact of having diabetes and the increased severity of the patient condition at hospital admission.

Conflicts of interest

The authors declare that they have no conflicts of interest.

P.T. O’Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, et al.
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol, 61 (2013), pp. e78-e140
P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blömstrom-Lundqvist, M.A. Borger, et al.
Task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC guidelines for the management of acute mmyocardial infarction in patients presenting with ST-segment elevation.
Eur Heart J, 33 (2012), pp. 2569-2619
T. Hasin, M. Hochadel, A.K. Gitt, S. Behar, H. Bueno, Y. Hasin.
Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus.
Am J Cardiol, 103 (2009), pp. 772-778
S.L. Woodfield, C.F. Lundergan, J.S. Reiner, S.W. Greenhouse, M.A. Thompson, S.C. Rohrbeck, et al.
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute mmyocardial infarction: the GUSTO-I experience.
J Am Coll Cardiol, 28 (1996), pp. 1661-1669
R.J. Goldberg, P.G. Steg, I Sadiq, G.B. Granger, E.A. Jackson, A. Budaj, et al.
Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE Registry).
Am J Cardiol, 89 (2002), pp. 791-796
S. Ribeiro, A. Gaspar, S. Rocha, S. Nabais, P. Azevedo, A. Salgado, et al.
Predictors of pre-hospital delay in patients with ST-segment elevation myocardial infarction.
Rev Port Cardiol, 29 (2010), pp. 1521-1532
R.J. Goldberg, F.A. Spencer, K.A. Fox, D. Brieger, G. Steg, E. Gurfinkel, et al.
Prehospital delay in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
Am J Cardiol, 103 (2009), pp. 598-603
W.S. Leslie, A. Urie, J. Hooper, C.E. Morrison.
Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care.
Heart, 84 (2000), pp. 137-141
J. Latour-Pérez, M.P. Fuset-Cabanes, M. Ruano-Marco, F. del Nogal-Sáez, J. Cunat-de la Hoz, J.M. Alcoverro-Pedrola, et al.
ARIAM Análisis del corte 2013,
D.A. Morrow, E.M. Antman, A. Charlesworth, R. Cairns, S.A. Murphy, J.A. de Lemos, et al.
TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy.
Circulation, 102 (2000), pp. 2031-2037
K.A.A. Fox, O.H. Dabbous, R.J. Goldberg, K.S. Pieper, K.A. Eagle, F. van de Werf, et al.
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).
S. Subherwal, R.G. Bach, A.Y. Chen, B.F. Gage, S.V. Rao, L.K. Newby, et al.
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA Guidelines) bleeding score.
Circulation, 119 (2009), pp. 1873-1882
M. Colmenero-Ruiz, A. Reina-Toral, M.M. Jimenez-Quintana, E. Aguayo-de-Hoyos, M. Ruiz-Bailén, A. García-Alcántara, et al.
Variabilidad en el manejo del infarto agudo de miocardio en el registro ARIAM en el año 2002.
Med Intensiva, 29 (2005), pp. 420-429
S.T. Nauta, J.W. Deckers, K.M. Akkerhuis, R.T. van Domburg.
Short-long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008.
Diab Care, 35 (2012), pp. 2043-2047

Please cite this article as: Baeza-Román A, de Miguel-Balsa E, Latour-Pérez J, Díaz de Antoñana-Saez V, Arguedas-Cervera J, Mira-Sánchez E, et al. Accesibilidad al sistema sanitario de los pacientes diabéticos con síndrome coronario agudo con elevación del segmento ST. Med Intensiva. 2016;40:90–95.

The members of the ARIAM-SEMICYUC Group work in Intensive Care / Coronary Units of several Spanish hospitals.

Medicina Intensiva (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.